Listing 1 - 10 of 29 | << page >> |
Sort by
|
Choose an application
There is a long-standing consensus that Solomon's prayer in 1 Kings 8 characterizes YHWH as having been 'relocated' to heaven and therefore no longer present in the temple. This study is the first sustained attempt to challenge that view. It does so by focusing on a hitherto overlooked collocation within the chapter, and concludes that the prayer portrays YHWH as being present both in heaven and in the building. Such a finding inevitably has consequences for wider issues involving divine presence both within and beyond the confines of 1 Kings 8. These include a cluster of ideas traced to the large central section of the chapter and involving a purely transcendent Deity, a (semi-)independent divine "name" inhabiting the sanctuary and an effectively desacralized temple. All three, together with the scholarly construct known as Name Theology, are called into question if YHWH is indeed represented as being localized within the temple.
Presence of God --- 222.6 --- 222.6 Livres de Samuel. Les Rois. David. Salomon. Elia. Elisa. Josias --- 222.6 Samuelboeken. Boeken der koningen. David. Salomon. Elia. Elisa. Josias --- Livres de Samuel. Les Rois. David. Salomon. Elia. Elisa. Josias --- Samuelboeken. Boeken der koningen. David. Salomon. Elia. Elisa. Josias --- God --- Schechinah --- Shechina --- Shechinah --- Shekhinah --- Shekina --- Shekinah --- Presence --- Omnipresence --- Temple of Jerusalem (Jerusalem) --- In the Bible. --- Bible. --- Criticism, interpretation, etc.
Choose an application
The series Beihefte zur Zeitschrift für die alttestamentliche Wissenschaft (BZAW) covers all areas of research into the Old Testament, focusing on the Hebrew Bible, its early and later forms in Ancient Judaism, as well as its branching into many neighboring cultures of the Ancient Near East and the Greco-Roman world.
222.6 --- #GBIB: jesuitica --- 222.6 Livres de Samuel. Les Rois. David. Salomon. Elia. Elisa. Josias --- 222.6 Samuelboeken. Boeken der koningen. David. Salomon. Elia. Elisa. Josias --- Livres de Samuel. Les Rois. David. Salomon. Elia. Elisa. Josias --- Samuelboeken. Boeken der koningen. David. Salomon. Elia. Elisa. Josias --- Temple of Jerusalem (Jerusalem) --- Bible. --- Kings (Books of the Old Testament) --- Koenige (Books of the Old Testament) --- Könige (Books of the Old Testament) --- Königsbücher (Book of the Old Testament) --- Koningen (Book of the Old Testament) --- Melakhim (Books of the Old Testament) --- Criticism, interpretation, etc. --- Lord's Supper --- Biblical teaching. --- Bible
Choose an application
Crop contamination by mycotoxins is a global problem that poses significant economic burdens due to a number of factors, including the food/feed losses that are caused by reduced production rates; the resulting adverse effects on human and animal health and productivity; and the trade losses associated with the costs incurred by inspection, sampling, and analysis before and after shipments. In this scenario, the development of fit-for-purpose analytical methods for regulated and (re)-emerging mycotoxins continues to be a dynamic research area. Some of the current trends in this research area are presented in this book. The collected contributions address either the need for improved methods for mycotoxin detection addressed by new or incoming regulation (ergot alkaloids and Alternaria toxins) as well as methods for the detection of multiple mycotoxins. New approaches to enhance the performance of well-established methodologies, such as the enzyme-linked immunosorbent assay (ELISA) and fluorescence polarization immunoassays (FPIA), are also addressed.
Research & information: general --- Chemistry --- Analytical chemistry --- FPIA --- mycotoxin --- OTA --- detection methods --- food safety --- monoclonal antibody (mAb) --- tracer --- HPLC --- trichothecenes --- zearalenone --- Fusarium toxins --- wheat --- liquid chromatography-mass spectrometry --- official control --- collaborative study --- ergot alkaloids --- sum parameter method --- hydrazinolysis --- esterification --- swine feed --- dairy feed --- UHPLC-MS/MS --- aflatoxin B1 --- recombinant AflR gene --- VICAM --- I-ELISA --- peanut --- wheat flour --- milk powder --- LC-MS/MS method --- cereal products --- occurrence --- alternariol --- antibody --- ELISA --- hapten design --- immunoassay --- linker site --- FPIA --- mycotoxin --- OTA --- detection methods --- food safety --- monoclonal antibody (mAb) --- tracer --- HPLC --- trichothecenes --- zearalenone --- Fusarium toxins --- wheat --- liquid chromatography-mass spectrometry --- official control --- collaborative study --- ergot alkaloids --- sum parameter method --- hydrazinolysis --- esterification --- swine feed --- dairy feed --- UHPLC-MS/MS --- aflatoxin B1 --- recombinant AflR gene --- VICAM --- I-ELISA --- peanut --- wheat flour --- milk powder --- LC-MS/MS method --- cereal products --- occurrence --- alternariol --- antibody --- ELISA --- hapten design --- immunoassay --- linker site
Choose an application
Crop contamination by mycotoxins is a global problem that poses significant economic burdens due to a number of factors, including the food/feed losses that are caused by reduced production rates; the resulting adverse effects on human and animal health and productivity; and the trade losses associated with the costs incurred by inspection, sampling, and analysis before and after shipments. In this scenario, the development of fit-for-purpose analytical methods for regulated and (re)-emerging mycotoxins continues to be a dynamic research area. Some of the current trends in this research area are presented in this book. The collected contributions address either the need for improved methods for mycotoxin detection addressed by new or incoming regulation (ergot alkaloids and Alternaria toxins) as well as methods for the detection of multiple mycotoxins. New approaches to enhance the performance of well-established methodologies, such as the enzyme-linked immunosorbent assay (ELISA) and fluorescence polarization immunoassays (FPIA), are also addressed.
FPIA --- mycotoxin --- OTA --- detection methods --- food safety --- monoclonal antibody (mAb) --- tracer --- HPLC --- trichothecenes --- zearalenone --- Fusarium toxins --- wheat --- liquid chromatography–mass spectrometry --- official control --- collaborative study --- ergot alkaloids --- sum parameter method --- hydrazinolysis --- esterification --- swine feed --- dairy feed --- UHPLC-MS/MS --- aflatoxin B1 --- recombinant AflR gene --- VICAM --- I-ELISA --- peanut --- wheat flour --- milk powder --- LC-MS/MS method --- cereal products --- occurrence --- alternariol --- antibody --- ELISA --- hapten design --- immunoassay --- linker site --- n/a --- liquid chromatography-mass spectrometry
Choose an application
Throughout history, wildlife has been an important source of infectious diseases transmissible to humans. Today, zoonoses with a wildlife reservoir constitute a major public health problem, affecting all continents. The importance of such zoonoses is increasingly recognized, and the need for more attention in this area is being addressed. The total number of zoonoses is unknown, some 1,415 known human pathogens have been catalogued, and 62% are of zoonotic origin [1]. With time, more and more human pathogens are found to be of animal origin. Moreover, most emerging infectious diseases in humans are zoonoses. Wild animals seem to be involved in the epidemiology of most zoonoses and serve as major reservoirs for transmission of zoonotic agents to domestic animals and humans [2]. The concept of the ‘One Health’ approach involving collaboration between veterinary and medical scientists, policy makers, and public health officials, is necessary to foster joint cooperation and control of emerging zoonotic diseases [3]. Zoonotic diseases caused by a wide range of arthropods, bacteria, helminths, protozoans, and viruses can cause serious and even life-threatening clinical conditions in animals, with a number of them also affecting the human population due to their zoonotic potential. The aim of the current Special Issue is to cover recent and novel research trends in zoonotic diseases in wildlife, including the relevant topics related to wildlife, zoonosis, public health, emerging diseases, infectious diseases and parasitic diseases.
Research & information: general --- Biology, life sciences --- Zoology & animal sciences --- west nile virus --- arbovirus --- zoonotic --- macaque --- bats --- c-ELISA --- RT-PCR --- Anaplasma phagocytophilum --- zoonosis --- tick --- wild ungulates --- phylogenesis --- molecular epidemiology --- Coxiella burnetii --- Q fever --- serology --- epidemiology --- wildlife --- European bison --- micromammals --- Cryptosporidium --- Giardia --- Blastocystis --- Enterocytozoon bieneusi --- Balantioides coli --- Troglodytella --- non-human primates --- rats --- zoological garden --- one health --- Helicobacter spp. --- PCR --- Sus scrofa --- Meles meles --- badger --- tuberculosis --- Mycobacterium tuberculosis complex --- P22 ELISA --- isolation --- cattle --- Atlantic Spain --- filter card --- faeces --- transportation --- storage --- preservation --- Giardia duodenalis --- Cryptosporidium hominis --- seroprevalence --- ruminants --- humans --- dust --- aerosols --- Salmonella --- turtles --- wildlife rescue centres --- camera-traps --- interactions --- wildlife-livestock interface --- non-tuberculous mycobacteria --- Leptospira interrogans --- microscopic agglutination test --- Slovenia --- n/a
Choose an application
Throughout history, wildlife has been an important source of infectious diseases transmissible to humans. Today, zoonoses with a wildlife reservoir constitute a major public health problem, affecting all continents. The importance of such zoonoses is increasingly recognized, and the need for more attention in this area is being addressed. The total number of zoonoses is unknown, some 1,415 known human pathogens have been catalogued, and 62% are of zoonotic origin [1]. With time, more and more human pathogens are found to be of animal origin. Moreover, most emerging infectious diseases in humans are zoonoses. Wild animals seem to be involved in the epidemiology of most zoonoses and serve as major reservoirs for transmission of zoonotic agents to domestic animals and humans [2]. The concept of the ‘One Health’ approach involving collaboration between veterinary and medical scientists, policy makers, and public health officials, is necessary to foster joint cooperation and control of emerging zoonotic diseases [3]. Zoonotic diseases caused by a wide range of arthropods, bacteria, helminths, protozoans, and viruses can cause serious and even life-threatening clinical conditions in animals, with a number of them also affecting the human population due to their zoonotic potential. The aim of the current Special Issue is to cover recent and novel research trends in zoonotic diseases in wildlife, including the relevant topics related to wildlife, zoonosis, public health, emerging diseases, infectious diseases and parasitic diseases.
west nile virus --- arbovirus --- zoonotic --- macaque --- bats --- c-ELISA --- RT-PCR --- Anaplasma phagocytophilum --- zoonosis --- tick --- wild ungulates --- phylogenesis --- molecular epidemiology --- Coxiella burnetii --- Q fever --- serology --- epidemiology --- wildlife --- European bison --- micromammals --- Cryptosporidium --- Giardia --- Blastocystis --- Enterocytozoon bieneusi --- Balantioides coli --- Troglodytella --- non-human primates --- rats --- zoological garden --- one health --- Helicobacter spp. --- PCR --- Sus scrofa --- Meles meles --- badger --- tuberculosis --- Mycobacterium tuberculosis complex --- P22 ELISA --- isolation --- cattle --- Atlantic Spain --- filter card --- faeces --- transportation --- storage --- preservation --- Giardia duodenalis --- Cryptosporidium hominis --- seroprevalence --- ruminants --- humans --- dust --- aerosols --- Salmonella --- turtles --- wildlife rescue centres --- camera-traps --- interactions --- wildlife-livestock interface --- non-tuberculous mycobacteria --- Leptospira interrogans --- microscopic agglutination test --- Slovenia --- n/a
Choose an application
Monoclonal antibodies (mAbs) are among the most specialised molecules for the recognition and capture of specific analytes. Hundreds of thousands of mAbs have been generated for a large number of different antigens with increasing affinity and specificity and are available for the most diverse purposes. Many of them have been validated as irreplaceable agents for diagnosis and therapy or as unique reagents for research. Others have been developed using emerging technologies that avoid the need for animal immunisation. This short book strives to gather the perspective view of the various contributing authors and to survey the new strategic assets adopted to generate novel monoclonal antibodies or surrogates, such as Fab, Fab2, ScFv and nanobodies, which have an increasing impact in biomedicine as therapeutic or diagnostic assets in various diseases.
PRAME --- mAb --- bio-layer interferometry --- epitope identification --- monoclonal antibody --- free radical --- protein aggregation --- oxidation --- excipient --- foot-and-mouth disease virus --- type O --- type A --- phage display --- antibody --- competitive ELISA --- atherosclerosis --- nano-emulsion --- magnetic resonance imaging --- stealth --- human antibody --- C. auris --- candidiasis --- multidrug resistance --- monoclonal antibodies --- universal antibodies --- cell wall --- passive immunization --- cell-based panning --- semi-automated cell panning --- FGFR3-specific antibody
Choose an application
Throughout history, wildlife has been an important source of infectious diseases transmissible to humans. Today, zoonoses with a wildlife reservoir constitute a major public health problem, affecting all continents. The importance of such zoonoses is increasingly recognized, and the need for more attention in this area is being addressed. The total number of zoonoses is unknown, some 1,415 known human pathogens have been catalogued, and 62% are of zoonotic origin [1]. With time, more and more human pathogens are found to be of animal origin. Moreover, most emerging infectious diseases in humans are zoonoses. Wild animals seem to be involved in the epidemiology of most zoonoses and serve as major reservoirs for transmission of zoonotic agents to domestic animals and humans [2]. The concept of the ‘One Health’ approach involving collaboration between veterinary and medical scientists, policy makers, and public health officials, is necessary to foster joint cooperation and control of emerging zoonotic diseases [3]. Zoonotic diseases caused by a wide range of arthropods, bacteria, helminths, protozoans, and viruses can cause serious and even life-threatening clinical conditions in animals, with a number of them also affecting the human population due to their zoonotic potential. The aim of the current Special Issue is to cover recent and novel research trends in zoonotic diseases in wildlife, including the relevant topics related to wildlife, zoonosis, public health, emerging diseases, infectious diseases and parasitic diseases.
Research & information: general --- Biology, life sciences --- Zoology & animal sciences --- west nile virus --- arbovirus --- zoonotic --- macaque --- bats --- c-ELISA --- RT-PCR --- Anaplasma phagocytophilum --- zoonosis --- tick --- wild ungulates --- phylogenesis --- molecular epidemiology --- Coxiella burnetii --- Q fever --- serology --- epidemiology --- wildlife --- European bison --- micromammals --- Cryptosporidium --- Giardia --- Blastocystis --- Enterocytozoon bieneusi --- Balantioides coli --- Troglodytella --- non-human primates --- rats --- zoological garden --- one health --- Helicobacter spp. --- PCR --- Sus scrofa --- Meles meles --- badger --- tuberculosis --- Mycobacterium tuberculosis complex --- P22 ELISA --- isolation --- cattle --- Atlantic Spain --- filter card --- faeces --- transportation --- storage --- preservation --- Giardia duodenalis --- Cryptosporidium hominis --- seroprevalence --- ruminants --- humans --- dust --- aerosols --- Salmonella --- turtles --- wildlife rescue centres --- camera-traps --- interactions --- wildlife-livestock interface --- non-tuberculous mycobacteria --- Leptospira interrogans --- microscopic agglutination test --- Slovenia --- west nile virus --- arbovirus --- zoonotic --- macaque --- bats --- c-ELISA --- RT-PCR --- Anaplasma phagocytophilum --- zoonosis --- tick --- wild ungulates --- phylogenesis --- molecular epidemiology --- Coxiella burnetii --- Q fever --- serology --- epidemiology --- wildlife --- European bison --- micromammals --- Cryptosporidium --- Giardia --- Blastocystis --- Enterocytozoon bieneusi --- Balantioides coli --- Troglodytella --- non-human primates --- rats --- zoological garden --- one health --- Helicobacter spp. --- PCR --- Sus scrofa --- Meles meles --- badger --- tuberculosis --- Mycobacterium tuberculosis complex --- P22 ELISA --- isolation --- cattle --- Atlantic Spain --- filter card --- faeces --- transportation --- storage --- preservation --- Giardia duodenalis --- Cryptosporidium hominis --- seroprevalence --- ruminants --- humans --- dust --- aerosols --- Salmonella --- turtles --- wildlife rescue centres --- camera-traps --- interactions --- wildlife-livestock interface --- non-tuberculous mycobacteria --- Leptospira interrogans --- microscopic agglutination test --- Slovenia
Choose an application
Monoclonal antibodies (mAbs) are among the most specialised molecules for the recognition and capture of specific analytes. Hundreds of thousands of mAbs have been generated for a large number of different antigens with increasing affinity and specificity and are available for the most diverse purposes. Many of them have been validated as irreplaceable agents for diagnosis and therapy or as unique reagents for research. Others have been developed using emerging technologies that avoid the need for animal immunisation. This short book strives to gather the perspective view of the various contributing authors and to survey the new strategic assets adopted to generate novel monoclonal antibodies or surrogates, such as Fab, Fab2, ScFv and nanobodies, which have an increasing impact in biomedicine as therapeutic or diagnostic assets in various diseases.
Research & information: general --- Biology, life sciences --- PRAME --- mAb --- bio-layer interferometry --- epitope identification --- monoclonal antibody --- free radical --- protein aggregation --- oxidation --- excipient --- foot-and-mouth disease virus --- type O --- type A --- phage display --- antibody --- competitive ELISA --- atherosclerosis --- nano-emulsion --- magnetic resonance imaging --- stealth --- human antibody --- C. auris --- candidiasis --- multidrug resistance --- monoclonal antibodies --- universal antibodies --- cell wall --- passive immunization --- cell-based panning --- semi-automated cell panning --- FGFR3-specific antibody --- PRAME --- mAb --- bio-layer interferometry --- epitope identification --- monoclonal antibody --- free radical --- protein aggregation --- oxidation --- excipient --- foot-and-mouth disease virus --- type O --- type A --- phage display --- antibody --- competitive ELISA --- atherosclerosis --- nano-emulsion --- magnetic resonance imaging --- stealth --- human antibody --- C. auris --- candidiasis --- multidrug resistance --- monoclonal antibodies --- universal antibodies --- cell wall --- passive immunization --- cell-based panning --- semi-automated cell panning --- FGFR3-specific antibody
Choose an application
Art --- art [discipline] --- identity --- globalization --- Orta, Jorge --- Geoffroy, Thierry --- Fakoor, Nazanin --- Bassiouni, Marwan --- Blok, Sarah --- Vaassen, Sanne --- Luna, Angela --- Ali, Alia --- Hazo-Santorin, Anais --- Brans, Berre --- Bakalov, Christian --- Joolen, van, Elisa --- Lutgerink, Elke --- Storey, Helen --- Alpha, Ines --- Cope, Jo --- Konno, Lisa --- Heidingsfeld, Lotje --- Steinhaeusser, Mona --- Lamrabat, Mous --- Manzo, Teresa --- Borght, Van der, Tom --- Orta, Lucy --- CFGNY [New York, N.Y.] --- Das Leben am Haverkamp [Den Haag] --- Sheltersuit [Enschede] --- The Fabricant [Amsterdam] --- Woman Cave Collective [Montreuil]
Listing 1 - 10 of 29 | << page >> |
Sort by
|